# NIAID BIG EFFECT TRIAL (BET) FOR COVID-19

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2021 · $24,161,705

## Abstract

To support the Big Effect Trial (BET) to evaluate therapeutic agents against COVID-19.

## Key facts

- **NIH application ID:** 10330402
- **Project number:** 75N91019D00024-P00002-759102000011-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** BETH BASELER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $24,161,705
- **Award type:** —
- **Project period:** 2020-05-01 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10330402

## Citation

> US National Institutes of Health, RePORTER application 10330402, NIAID BIG EFFECT TRIAL (BET) FOR COVID-19 (75N91019D00024-P00002-759102000011-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10330402. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*